Lifecore Biomedical, Inc.
LFCR
$7.63
$0.415.68%
NASDAQ
| 05/25/2025 | 02/23/2025 | 11/24/2024 | 08/25/2024 | 05/26/2024 | |
|---|---|---|---|---|---|
| Net Income | -422.29% | -121.19% | 80.30% | 106.58% | 112.07% |
| Total Depreciation and Amortization | 0.92% | 0.21% | -13.52% | -25.85% | -37.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 319.72% | 2,070.33% | -77.65% | -126.09% | -132.57% |
| Change in Net Operating Assets | -26.93% | 182.80% | -133.44% | -8.62% | -118.69% |
| Cash from Operations | -180.16% | 129.50% | 102.59% | 132.20% | 101.47% |
| Capital Expenditure | 27.07% | 38.61% | 36.65% | 27.80% | 14.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 65.13% | 67.82% | -48.65% | -73.60% | -282.35% |
| Total Debt Issued | -14.05% | -19.15% | -13.83% | -16.98% | -17.56% |
| Total Debt Repaid | 0.50% | -8.71% | 11.02% | 17.22% | 17.33% |
| Issuance of Common Stock | 3,195.30% | 3,195.30% | 3,192.96% | -99.98% | -85.52% |
| Repurchase of Common Stock | -740.79% | -1,071.72% | -256.33% | -61.86% | 66.37% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -58.80% | -25.53% | 218.50% | 178.83% | 178.83% |
| Cash from Financing | -14.45% | -81.00% | -24.90% | -85.36% | -81.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.15% | 1,805.69% | 272.73% | -170.63% | -160.92% |